‘She just needs to try harder’: Misunderstanding of PCOS and its impact on metabolic syndromeImbalances caused by PCOS put women at risk for metabolic syndrome, but the condition continues to be misdiagnosed, says Ontario physician Dr. Ashley White. GLP-1 receptor agonists and the risk of suicide, self-harm and suicidal ideation Health Canada has reviewed evidence on the link between glucagon-like peptide-1 (GLP-1) receptor agonists and suicide, self-harm and suicidal/self-harm ideation. Is there still a place for bariatric surgery in the era of GLP-1 receptor agonist drugs? Surgery still confers the highest degree of long-term and sustained weight loss but multiple comorbidities are more likely, study says. Quiz: Caring for patients after their bariatric surgery Test your knowledge of post-operative care for patients following bariatric surgery. First needleless device for insulin administration now available in Canada InsuJet, a needle-free insulin injection system, uses jet-injection technology to deliver insulin subcutaneously in persons six years of age or older. Tirzepatide reduces body weight and slows progression to diabetes in patients with obesity and prediabetes Three-year study shows significant and sustained weight reduction with tirzepatide and a markedly lower risk of progression from prediabetes to type 2 diabetes. New links found between Type 2 diabetes and pancreatic cancer Study shows how type 2 diabetes can cause epigenetic changes leading to pancreatic cancer An overview of diabetic retinopathy Reducing progression through patient education, early detection and treatment. Health Canada advisory: SGLT2 inhibitors and prolonged or incident diabetic ketoacidosis Take note of this Health Canada advisory as part of our October drug news update. Talking with patients about continuous glucose monitoring 1 2 3 4 5 Next Last
